Peptides – Cellgenic https://cellgenic.com Explore Cellgenic's advanced regenerative medicine products, specializing in high-quality exosomes for therapeutic applications. Purchase exosomes online to enhance your practice with cutting-edge solutions. Thu, 09 Oct 2025 02:43:38 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 https://cellgenic.com/wp-content/uploads/2021/05/cropped-Cellgenic-Website-Bases-32x32.png Peptides – Cellgenic https://cellgenic.com 32 32 Muse Cells https://cellgenic.com/product/muse-cells/ Thu, 09 Oct 2025 02:35:38 +0000 https://cellgenic.com/?post_type=product&p=3230 The post Muse Cells appeared first on Cellgenic.

]]> The post Muse Cells appeared first on Cellgenic.

]]> NAD+, 1300mg /GHK-CU, 10mg Patch (6×12 Hour Patches) https://cellgenic.com/product/nad-1300mg-ghk-cu-10mg-patch-6x12-hour-patches/ Thu, 09 Oct 2025 02:28:22 +0000 https://cellgenic.com/?post_type=product&p=3227 The post NAD+, 1300mg /GHK-CU, 10mg Patch (6×12 Hour Patches) appeared first on Cellgenic.

]]> The post NAD+, 1300mg /GHK-CU, 10mg Patch (6×12 Hour Patches) appeared first on Cellgenic.

]]> BPC-157, 2000mcg / NAD+, 250 mg / GHKCU, 10mg Patch (6×12 Hour Patches) https://cellgenic.com/product/bpc-157-2000mcg-nad-250-mg-ghkcu-10mg-patch-6x12-hour-patches/ Thu, 09 Oct 2025 02:23:23 +0000 https://cellgenic.com/?post_type=product&p=3224 The post BPC-157, 2000mcg / NAD+, 250 mg / GHKCU, 10mg Patch (6×12 Hour Patches) appeared first on Cellgenic.

]]> The post BPC-157, 2000mcg / NAD+, 250 mg / GHKCU, 10mg Patch (6×12 Hour Patches) appeared first on Cellgenic.

]]> Cellgenic Selank, 10mg Nasal https://cellgenic.com/product/cellgenic-selank-10mg-nasal/ Sun, 28 Sep 2025 19:56:20 +0000 https://cellgenic.com/?post_type=product&p=3219 What is Selank Nasal? Selank, 10mg Nasal SELANK 10MG NASAL APPLICATION PROTOCOL Dosage: 300 mcg (= 4.5 sprays). Protocol: Mild anxiety / performance enhancement: 5 days ON / 2 OFF. Chronic stress or immunity: 10-14 consecutive days, then rest 7-14 days. Prolonged cognitive use: 4 weeks ON, then rest 1-2 weeks. Notes: Anxiolytic, non-sedative, cognitive...

The post Cellgenic Selank, 10mg Nasal appeared first on Cellgenic.

]]>

What is Selank Nasal?

Selank, 10mg Nasal

SELANK 10MG NASAL

APPLICATION PROTOCOL

Dosage:

300 mcg (= 4.5 sprays).

Protocol:

Mild anxiety / performance enhancement: 5 days ON / 2 OFF.
Chronic stress or immunity: 10-14 consecutive days, then rest 7-14 days.
Prolonged cognitive use: 4 weeks ON, then rest 1-2 weeks.
Notes: Anxiolytic, non-sedative, cognitive support, and immunomodulatory.

The post Cellgenic Selank, 10mg Nasal appeared first on Cellgenic.

]]> PT-141, 10mg/Oxytocin, 5mg Nasal Cellgenic https://cellgenic.com/product/pt-141-10mg-oxytocin-5mg-nasal-cellgenic/ Sun, 28 Sep 2025 19:48:16 +0000 https://cellgenic.com/?post_type=product&p=3215 What is PT-141 / Oxytocin Nasal? PT-141, 10mg / Oxytocin, 5mg Nasal PT-141 10MG / OXYTOCIN 5MG NASAL APPLICATION PROTOCOL Dosage: 100-400 mcg total. 2 sprays = 133 mcg PT-141 + 66.6 mcg Oxytocin. 4 sprays = 267 mcg PT-141 + 133.2 mcg Oxytocin. 6 sprays = 400 mcg PT-141 + 199.8 mcg Oxytocin. Protocol:...

The post PT-141, 10mg/Oxytocin, 5mg Nasal Cellgenic appeared first on Cellgenic.

]]>

What is PT-141 / Oxytocin Nasal?

PT-141, 10mg / Oxytocin, 5mg Nasal

PT-141 10MG / OXYTOCIN 5MG NASAL

APPLICATION PROTOCOL

Dosage:

100-400 mcg total.
2 sprays = 133 mcg PT-141 + 66.6 mcg Oxytocin.
4 sprays = 267 mcg PT-141 + 133.2 mcg Oxytocin.
6 sprays = 400 mcg PT-141 + 199.8 mcg Oxytocin.

Protocol:

Start with 2 sprays.
Wait 15-20 min to assess tolerance (nausea).
Continue with 2-4 additional sprays as needed.
Notes: It is recommended to take an L-theanine capsule 30 min before to reduce nausea.

The post PT-141, 10mg/Oxytocin, 5mg Nasal Cellgenic appeared first on Cellgenic.

]]> NAD+, 500mg Nasal WHLB https://cellgenic.com/product/nad-500mg-nasal-whlb/ Sun, 28 Sep 2025 19:43:04 +0000 https://cellgenic.com/?post_type=product&p=3212 What is NAD+ Nasal? NAD+, 500mg Nasal WHLB NAD+ 500MG NASAL WHLB APPLICATION PROTOCOL Dosage: Maintenance/Cognitive: 10-20 mg (3-6 sprays AM, 3-5x per week). Mitochondrial/Anti-aging: 10-30 mg (3-9 sprays AM, 3x per week). Cycle: Continuous, following the above scheme. Notes: Cognitive support, neuroprotective, and post-stress recovery.

The post NAD+, 500mg Nasal WHLB appeared first on Cellgenic.

]]>

What is NAD+ Nasal?

NAD+, 500mg Nasal WHLB

NAD+ 500MG NASAL WHLB

APPLICATION PROTOCOL

Dosage:

Maintenance/Cognitive: 10-20 mg (3-6 sprays AM, 3-5x per week).
Mitochondrial/Anti-aging: 10-30 mg (3-9 sprays AM, 3x per week).

Cycle:

Continuous, following the above scheme.
Notes: Cognitive support, neuroprotective, and post-stress recovery.

The post NAD+, 500mg Nasal WHLB appeared first on Cellgenic.

]]> Cellgenic Semax Nasal, 10mg https://cellgenic.com/product/cellgenic-semax-nasal-10mg/ Sun, 28 Sep 2025 19:36:11 +0000 https://cellgenic.com/?post_type=product&p=3209 What is Semax Nasal? Semax Nasal, 10mg SEMAX NASAL 10MG APPLICATION PROTOCOL Dosage: 300 mcg (~ 4.5 sprays). Frequency: 1-3 times/day. Cycle: 5 days ON / 2 OFF for 4 weeks. Prolonged use: 8-12 weeks with 5 ON / 2 OFF, then rest for 4 weeks. Notes: Cognitive support, neuroprotective, and post-stress

The post Cellgenic Semax Nasal, 10mg appeared first on Cellgenic.

]]>

What is Semax Nasal?

Semax Nasal, 10mg

SEMAX NASAL 10MG

APPLICATION PROTOCOL

Dosage:

300 mcg (~ 4.5 sprays).

Frequency:

1-3 times/day.

Cycle:

5 days ON / 2 OFF for 4 weeks. Prolonged use: 8-12 weeks with 5 ON / 2 OFF, then rest for 4 weeks.
Notes: Cognitive support, neuroprotective, and post-stress

The post Cellgenic Semax Nasal, 10mg appeared first on Cellgenic.

]]> Chronos: (MOTS-c + AMPK Activator) https://cellgenic.com/product/chronos-mots-c-ampk-activator/ Sat, 27 Sep 2025 18:43:50 +0000 https://cellgenic.com/?post_type=product&p=3200 What is Chronos MOTS-C Complex? The combination of mitochondrial-derived peptide MOTS-c with an AMP-activated protein kinase (AMPK) activator represents a novel and synergistic approach to modulating metabolism, enhancing mitochondrial function, and optimizing cellular resilience. Both compounds converge on the AMPK-PGC-1α axis and offer complementary mechanisms that address metabolic dysfunction, inflammation, and aging. Chronos MOTS-C 10mg...

The post Chronos: (MOTS-c + AMPK Activator) appeared first on Cellgenic.

]]>

What is Chronos MOTS-C Complex?

The combination of mitochondrial-derived peptide MOTS-c with an AMP-activated protein kinase (AMPK) activator represents a novel and synergistic approach to modulating metabolism, enhancing mitochondrial function, and optimizing cellular resilience. Both compounds converge on the AMPK-PGC-1α axis and offer complementary mechanisms that address metabolic dysfunction, inflammation, and aging.

Chronos MOTS-C 10mg | AMPK Activator 25mg

EXTENDED PROTOCOL

MOTS-c Mechanism of Action:

MOTS-c is a 16-amino acid peptide encoded by mitochondrial DNA, acting as a retrograde signaling molecule from the mitochondria to the nucleus. It provides AMPK activation via AICAR mimetic function, enhances insulin sensitivity and glucose uptake, promotes fatty acid oxidation, and reduces oxidative stress through Nrf2 activation.

AMPK Activator Mechanism of Action:

AMPK activators stimulate the AMPK pathway either by mimicking AMP or inhibiting mitochondrial complex I. Key actions include mitochondrial biogenesis via PGC-1α, induction of autophagy via ULK1 activation, metabolic reprogramming toward fatty acid oxidation, and anti-inflammatory effects via NF-κB inhibition.

Synergistic Integration:

The synergy is primarily based on their joint activation of the AMPK-PGC-1α axis through complementary mechanisms. This dual approach creates sustained AMPK activation, improved glucose homeostasis, enhanced fat metabolism, boosted energy output, robust anti-inflammatory effects, and slowed biological aging.

Clinical Applications:

  • Metabolic Optimization – Enhances insulin sensitivity, glucose uptake, and fatty acid oxidation.
  • Mitochondrial Support – Stimulates biogenesis, boosts energy output, reduces mitochondrial decay.
  • Longevity & Anti-Senescence – Activates FOXO and SIRT signaling, enhances autophagy and mitophagy.
  • Inflammation & Stress Resistance – Lowers NF-κB activity, improves recovery from metabolic stress.
  • Weight Management – Supports metabolic syndrome recovery and healthy body composition.
  • Performance Optimization – Provides exercise-mimetic effects to extend healthspan.

Dosage & Administration:

25–100 IU via subcutaneous (SC) or intramuscular (IM) route. Frequency: 3–7 times per week (daily or near-daily).

Cycle Length:

6–12 weeks for metabolic optimization and mitochondrial support. Best results observed with continuous use. Cycles can be repeated for ongoing support.

Reassessment:

After 30 days to adjust dosing and frequency based on individual response and metabolic markers.

Monitoring Parameters:

Glucose control markers (fasting glucose, HbA1c), mitochondrial performance indicators (VO₂ max, lactate threshold), and inflammation markers (CRP, IL-6).
Especially relevant for longevity medicine, metabolic syndrome, performance optimization, and immune modulation applications.

Synergistic Pathway Benefits:

  • AMPK Activation – Indirect via AICAR-mimetic + Direct activation = Sustained AMPK activation
  • Glucose Metabolism – GLUT4 upregulation + Insulin sensitivity = Improved glucose homeostasis
  • Fat Oxidation – β-oxidation promotion + ACC inhibition = Enhanced fat metabolism
  • Mitochondrial Health – Mitophagy enhancement + Biogenesis induction = Boosted energy output
  • Inflammation Control – Nrf2 activation + NF-κB inhibition = Robust anti-inflammatory effect
  • Longevity – Senescence reduction + Autophagy & mTOR inhibition = Slowed biological aging

The post Chronos: (MOTS-c + AMPK Activator) appeared first on Cellgenic.

]]> Eon: LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed) https://cellgenic.com/product/eon-ll-37-2mg-egcg-250mg-inclusion-complexed-quercetin-250mg-inclusion-complexed/ Sat, 27 Sep 2025 18:39:47 +0000 https://cellgenic.com/?post_type=product&p=3197 What is Eon LL-37 Complex? A comprehensive antimicrobial and immune modulation formulation combining LL-37 cathelicidin with enhanced EGCG and Quercetin. This synergistic blend provides broad-spectrum pathogen clearance, immune rebalancing, mucosal barrier repair, and anti-senescence effects for chronic infections, autoimmune conditions, and post-viral recovery. Eon LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion...

The post Eon: LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed) appeared first on Cellgenic.

]]>

What is Eon LL-37 Complex?

A comprehensive antimicrobial and immune modulation formulation combining LL-37 cathelicidin with enhanced EGCG and Quercetin. This synergistic blend provides broad-spectrum pathogen clearance, immune rebalancing, mucosal barrier repair, and anti-senescence effects for chronic infections, autoimmune conditions, and post-viral recovery.

Eon LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed)

EXTENDED PROTOCOL

LL-37:

Cationic antimicrobial peptide derived from cathelicidin (hCAP18). Disrupts bacterial, viral, and fungal membranes; effective against biofilms. Activates Toll-like receptors (TLR2, TLR9) and enhances chemotaxis of immune cells. Promotes angiogenesis and epithelial regeneration.

EGCG (Inclusion Complexed):

Polyphenol from green tea with enhanced bioavailability via cyclodextrin inclusion. Scavenges ROS and chelates metals; activates Nrf2. Suppresses NF-κB, IL-6, and TNF-α; reduces mast cell activation. Blocks viral entry and replication; interferes with bacterial quorum sensing.

Quercetin (Inclusion Complexed):

Flavonoid with enhanced absorption via cyclodextrin inclusion. Stabilizes mast cells, reducing histamine, prostaglandins, and leukotrienes. Inhibits NF-κB, COX-2, iNOS; acts as a zinc ionophore. Senolytic properties: clears senescent cells and suppresses SASP.

Synergistic Integration:

Multi-pathway pathogen kill, superior biofilm eradication, balanced immune response, mucosal resilience, chronic inflammation suppression, and tissue longevity through complementary mechanisms.

Strategic Applications:

  • Post-viral recovery (EBV, COVID) – viral clearance, immune regulation, anti-fibrosis.
  • MCAS / Histamine intolerance – mast cell stabilization and histamine burden reduction.
  • Autoimmune support (Hashimoto’s, lupus) – Treg upregulation + NF-κB suppression + barrier healing.
  • Gut/Lung Barrier Dysfunction – epithelial repair + inflammation control.
  • Chronic Infections (Lyme, Candida, SIBO) – biofilm destruction + antimicrobial + cytokine modulation.
  • Anti-aging & Inflammaging – senolytic + regenerative + anti-fibrotic effects.

Dosage & Administration:

25–100 IU via subcutaneous (SC), intramuscular (IM), or intravenous (IV) route. Frequency: 1–2 times per week.

Cycle Length:

2–4 weeks for antimicrobial effect or immune priming. Can be repeated depending on infection load or immune dysregulation status.

Clinical Applications:

Broad-spectrum antimicrobial action, immune priming & modulation, inflammation control & barrier protection, post-infection recovery, and anti-aging & inflammaging support.

Monitoring Parameters:

Inflammatory markers: CRP, IL-6, TNF-α. Immune profile: WBC differential, Treg/Th17 balance. Clinical outcomes: infection clearance, symptom regression, mucosal/gut health.
Especially valuable for patients with chronic infections, autoimmune conditions, and post-viral recovery needs.

Mechanistic Pathways:

  • Antimicrobial – Multi-pathway pathogen disruption and biofilm eradication
  • Biofilm Disruption – Superior matrix breakdown and adhesion inhibition
  • Immune Modulation – TLR activation, Treg boost, mast cell stabilization
  • Barrier Protection – Epithelial restoration, tight junction support, mucosal resilience
  • Anti-Inflammatory – NF-κB suppression, Nrf2 activation, endotoxin neutralization
  • Senescence/Aging – Tissue regeneration, fibrosis reduction, senolytic activity

The post Eon: LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed) appeared first on Cellgenic.

]]> Elysia: Gonadorelin, Oxytocin, DHEA, and PT- 141 (Her) https://cellgenic.com/product/elysia-gonadorelin-oxytocin-dhea-and-pt-141-her/ Sat, 27 Sep 2025 18:31:17 +0000 https://cellgenic.com/?post_type=product&p=3194 What is Elysia? Elysia is a female-optimized peptide complex designed to enhance sexual vitality, hormonal balance, and emotional intimacy. Its ingredients — Gonadorelin, Oxytocin, DHEA, and PT-141 — work synergistically across the hypothalamic-pituitary-gonadal (HPG) axis, neuroendocrine system, and limbic brain centers to address low libido, hormonal dysregulation, and intimacy challenges in women. Elysia Gonadorelin (Synthetic...

The post Elysia: Gonadorelin, Oxytocin, DHEA, and PT- 141 (Her) appeared first on Cellgenic.

]]>

What is Elysia?

Elysia is a female-optimized peptide complex designed to enhance sexual vitality, hormonal balance, and emotional intimacy. Its ingredients — Gonadorelin, Oxytocin, DHEA, and PT-141 — work synergistically across the hypothalamic-pituitary-gonadal (HPG) axis, neuroendocrine system, and limbic brain centers to address low libido, hormonal dysregulation, and intimacy challenges in women.

Elysia Gonadorelin (Synthetic GnRH) 1.4mg, Oxytocin 500mcg, DHEA (Dehydroepiandrosterone) 100mg, PT-141 (Bremelanotide) 1mg

EXTENDED PROTOCOL

Gonadorelin (Synthetic GnRH) 1.4mg:

Directly stimulates pituitary to release LH and FSH. Leads to estradiol and progesterone production in premenopausal women. Supports ovulation, fertility, and hormone cycling. Useful in hypogonadotropic hypogonadism, post-birth control, or amenorrhea.

Oxytocin 500mcg:

Enhances limbic system activation (emotion & bonding). Increases trust, empathy, and vulnerability. Improves vaginal lubrication and arousal. Facilitates blood flow and smooth muscle relaxation. Boosts orgasmic potential via uterine/vaginal contractions.

DHEA (Dehydroepiandrosterone) 100mg:

Converts to estrogen and testosterone locally in tissues (intracrinology). Enhances vaginal tissue health, elasticity, and sensitivity. Balances the stress response, especially under cortisol dominance. Improves mood, motivation, and libido.

PT-141 (Bremelanotide) 1mg:

Activates MC3R and MC4R in the brain to trigger sexual desire and arousal. Restores libido in hypoactive sexual desire disorder (HSDD). Enhances sexual motivation and receptivity. Works even when hormonal levels are normal but libido is low.

Additional Female Benefits:

  • Restores libido and lubrication after menopause or hormonal birth control.
  • Improves emotional vulnerability and trust in relationships.
  • Increases sexual receptivity and orgasmic intensity.
  • Reduces cortisol-driven sexual shutdown (Oxytocin + DHEA).
  • Boosts confidence, sensuality, and body-image through neuroendocrine activation.
  • Improves sexual health without synthetic hormone replacement.
  • Works with or without a functioning menstrual cycle.

Dosage & Administration:

10 IU daily via subcutaneous (SC) or intramuscular (IM) route. Cycle Length: 4–8 weeks or as clinically needed.

Special Consideration:

Dose should be reduced or paused during the menstrual cycle to avoid overstimulation of endogenous hormonal rhythms.

Clinical Applications:

Female hormonal remodeling, libido & sexual function enhancement, emotional intimacy & mood support, and vaginal & reproductive health improvement. Supports fertility signaling and ovulation when appropriate.

Monitoring Parameters:

Cycle regularity, libido scores, mood stability, and vaginal health should be tracked for optimization.
Duration: 4–8 weeks with flexibility to adjust based on cycle or symptoms.

Ideal Users of Elysia:

  • Women with low libido from stress, age, or medications
  • Women on or recovering from hormonal contraceptives or SSRI/SNRI medications
  • Women with postpartum hormone drop or anorgasmia
  • Perimenopausal and menopausal women seeking non-synthetic hormone support
  • Women in long-term relationships wanting to rekindle arousal and emotional bonding
  • Women needing HPG axis reactivation after stress-induced shutdown

The post Elysia: Gonadorelin, Oxytocin, DHEA, and PT- 141 (Her) appeared first on Cellgenic.

]]>